Research and development site of the pharmaceutical business of Johnson & Johnson at Horsham in Pennsylvania, run under the Janssen name until 2023 and now part of Johnson & Johnson Innovative Medicine. Carries out clinical development, translational research and regulatory and safety work for medicines in immunology, including treatments for psoriasis and inflammatory bowel disease, neuroscience, infectious disease and oncology, and hosts clinical operations, biostatistics and pharmacovigilance functions for the group.
No comments available.
Leave your rating & comment